An international team including researchers from Nvidia and Microsoft has used AI on a biological trove of more than a ...
Space.com on MSN
Viruses may be more powerful in the International Space Station's microgravity environment
The International Space Station (ISS) is a closed ecosystem, and the biology inside it — including its microbial residents — ...
Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.
Scientists are taking a multipronged approach to tackle this dangerous carrier of dengue, yellow fever and other noxious ...
Using ribosome engineering (RE), researchers from Shinshu University introduced mutations affecting the protein synthesis ...
Octopus and other cephalopods are good at hiding themselves—and are inspiring cutting-edge technologies that may help us do ...
Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...
Octopus and other cephalopods are good at hiding themselves—and are inspiring cutting-edge technologies that may help us do ...
Every year, millions of lives are suddenly, swiftly transformed by a stroke, which occurs when a blood vessel travelling ...
Fallout Season 2 finally introduces the Deathclaws, making them even scarier than the games do through a mix of practical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback